Glucagon-like peptide-1 (GLP-1) compounds have emerged as a compelling therapeutic strategy for managing metabolic syndromes. These naturally occurring molecules are secreted by the gut in response to nutrient intake, https://tirzapatide.com/collections/fda-registered-peptides/products/cjc-1295-w-dac